Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study.

José Juan Sánchez-HidalgoJuan Antonio Suárez-CuencaJosé Juan Lozano-NuevoVíctor Hugo García-LópezMaría Graciela Leal-GutiérrezSein Antonio León-AngelMaría Leslye Ramírez-VillaMartha Elena Rodea-RubioJosé Enrique González-HernándezJosé Antonio Canela-MayoralEduardo Murillo-HerediaEduardo Vera-GómezAlejandro Hernández-PatricioCarlos Ramiro Zamora-AlemánGabriela Alexandra Domínguez-PérezJuan Ariel Gutiérrez-BuendiaPaul Mondragón-Terán

Published in: Diabetology & metabolic syndrome (2021)

Urine transferrin correlated with subclinical atherogenesis in patients with t2DM without renal failure, suggesting its potential to identify cardiovascular risk in patients at very early nephropathy stage without microalbuminuria.

Keyphrases

type diabetes
metabolic syndrome
insulin resistance
skeletal muscle